Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

This Is What Whales Are Betting On Merck & Co

A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co.

Looking at options history for Merck & Co (NYSE:MRK) we detected 19 strange trades.

If we consider the specifics of each trade, it is accurate to state that 73% of the investors opened trades with bullish expectations and 26% with bearish.

From the overall spotted trades, 4 are puts, for a total amount of $220,560 and 15, calls, for a total amount of $550,403.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $77.5 to $110.0 for Merck & Co over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Merck & Co's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Merck & Co's whale activity within a strike price range from $77.5 to $110.0 in the last 30 days.

Merck & Co Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
MRK PUT TRADE BULLISH 03/17/23 $100.00 $88.8K 1.2K 193
MRK CALL SWEEP BULLISH 03/17/23 $90.00 $67.2K 1.6K 48
MRK CALL TRADE BEARISH 06/16/23 $105.00 $57.4K 1.6K 127
MRK PUT SWEEP BULLISH 11/18/22 $100.00 $50.5K 1.0K 615
MRK PUT SWEEP BEARISH 01/20/23 $77.50 $45.0K 7.0K 2.8K

Where Is Merck & Co Standing Right Now?

  • With a volume of 4,740,322, the price of MRK is down -0.01% at $101.58.
  • RSI indicators hint that the underlying stock may be overbought.
  • Next earnings are expected to be released in 84 days.

What The Experts Say On Merck & Co:

  • Atlantic Equities has decided to maintain their Overweight rating on Merck & Co, which currently sits at a price target of $122.
  • Guggenheim has decided to maintain their Buy rating on Merck & Co, which currently sits at a price target of $111.
  • Barclays has decided to maintain their Overweight rating on Merck & Co, which currently sits at a price target of $110.
  • Wells Fargo has decided to maintain their Overweight rating on Merck & Co, which currently sits at a price target of $110.
  • Morgan Stanley has decided to maintain their Equal-Weight rating on Merck & Co, which currently sits at a price target of $91.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Merck & Co, Benzinga Pro gives you real-time options trades alerts.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.